Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. Everything we do revolves around human and animal health and is reflected in our mission “Science For A Better Life”
At Pharmaceuticals, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. We conduct research and development activities at several locations, mainly in Germany, the United States, Japan, China, Finland and Norway.
Cancer Society of Finland
The Cancer Society of Finland consists of 12 regional cancer societies and six national patient organisations. The CSF maintains the Finnish Cancer Registry. Cancer Foundation Finland is a charitable organisation and the main private funder of cancer research in the country.
The strategy of the Cancer Society and the Cancer Foundation Finland is their pledge to act decisively to promote health, prevent cancer, support people with cancer and reduce the adverse effects of cancer throughout the country.
Colores is a member association of Cancer Society of Finland.
Cardirad Oy markets and distributes healthcare products and medicine in the Nordic and Baltic countries from the leading vendors of the world. Our primary focus is on invasive cardiology, radiology, and nuclear medicine.
We market SIRT (also known as radio-embolisation), which is a special type of internal radiotherapy that targets liver tumours inside the body with high doses of radiation. It involves injecting millions of tiny radioactive ‘beads’ called microspheres into the main blood vessel of the liver through a long thin tube (catheter). SIRT is used to treat liver tumours that cannot be removed by surgery. The two commonest uses of SIRT are to treat liver tumours that have spread from the bowel and primary liver cancer
Coloplast develops products and services that make life easier for people with very personal and private medical conditions.
Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.
Our business includes Ostomy Care, Continence Care, Wound & Skin Care and Interventional Urology. We operate globally and our organisation is about 12,000 people strong.
Dansac develops, manufactures and markets unique stoma care products that solve specific problems and improve quality of life for people with a stoma – and for people who work with stoma care. This is our mission!
Dansac focuses solely on stoma care, nothing else. We consider each stoma to be an individual case that requires unique care and products. We do not hesitate to find new ways and to think differently.
Hollister Incorporated is an independent, employee-owned company that develops, manufactures, and markets healthcare products and services worldwide.
We offer advanced medical products for Ostomy Care, which includes two strong global brands – Hollister Ostomy and Dansac Ostomy; Continence Care; Critical Care; and Wound Care. We also provide innovative healthcare programs and services, as well as educational materials for patients and healthcare professionals.
Digestive Cancers Europe
Digestive Cancers Europe DiCE is the voice of digestive cancer patients in Europe. Its aim is to save lives by bringing together all key stakeholders in the fight against these cancers. We are campaigning for the adoption of best practices in prevention, diagnosis, treatment and follow up.
Colores is a full member of DiCE.
Docrates Cancer Center
Docrates Cancer Center specialises in the diagnosis, treatment and follow-up care of cancer. Located in Finland’s capital, Helsinki, this state-of-the-art hospital is conveniently located offering direct access from major cities. An appointment with a specialist is arranged within 1-2 days, which means treatment can begin without delay – a vitally important factor in cancer treatment.
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years.
Founded in 1950, Ferring now employs more than 6,500 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.
Our vision is to make a difference in the lives of people globally through our innovative medicines, vaccines, biologic therapies, and consumer health and animal products. We aspire to being the best healthcare company in the world, and are dedicated to providing leading innovations and solutions for tomorrow. We have made it our mission to provide innovative, distinctive products and services that save and improve lives and satisfy customer needs.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Servier is an international and independent pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France. Since opening our first laboratory in 1954, we have been committed to therapeutic progress to serve patient needs with the help of healthcare professionals. We strive to provide future generations with a world where quality healthcare is available and accessible to all.
We are a leading force in cardiology—number 2 in Europe, number 5 worldwide—and oncology has become a top priority in recent years; we also manufacture high-quality generic drugs.
The Funding Centre for Social Welfare and Health Organisations (STEA) manages the funding granted for projects which are non-profit by nature and promote health and wellbeing, from the gaming revenue of Veikkaus Oy.
The funding granted from Veikkaus Oy’s revenue for projects related to arts, culture, and sports are managed by the Ministry of Education and Culture, and funding for projects related to the promotion of horse breeding and equestrian sports by the Ministry of Agriculture and Forestry.